Product Images Zejula
View Photos of Packaging, Labels & Appearance
- Molecular structure - zejula tab spl graphic 01
- Figure 1. Progression-Free Survival in Patients with HR-Deficient Tumors (Intent-to-Treat Population, n = 373) - zejula tab spl graphic 02
- Figure 2. Progression-Free Surivival in the Overall Population (Intent-to-Treat Population, n=733) - zejula tab spl graphic 03
- Figure 3. Progression-Free Survival in the gBRCAmut Cohort Based on IRC Assessment (Intent-to-Treat Population, n = 203) - zejula tab spl graphic 04
- Zejula 100 mg tablet 30 count label - zejula tab spl graphic 05
- Zejula 200 mg tablet 30 count label - zejula tab spl graphic 06
- Zejula 300 mg tablet 30 count label - zejula tab spl graphic 07
Product Label Images
The following 7 images provide visual information about the product associated with Zejula NDC 0173-0912 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Molecular structure - zejula tab spl graphic 01
Figure 1. Progression-Free Survival in Patients with HR-Deficient Tumors (Intent-to-Treat Population, n = 373) - zejula tab spl graphic 02
Figure 2. Progression-Free Surivival in the Overall Population (Intent-to-Treat Population, n=733) - zejula tab spl graphic 03
Figure 3. Progression-Free Survival in the gBRCAmut Cohort Based on IRC Assessment (Intent-to-Treat Population, n = 203) - zejula tab spl graphic 04
Zejula 100 mg tablet 30 count label - zejula tab spl graphic 05
Zejula 200 mg tablet 30 count label - zejula tab spl graphic 06
Zejula 300 mg tablet 30 count label - zejula tab spl graphic 07
